573 related articles for article (PubMed ID: 18406889)
1. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
2. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte telomere length correlates with in vitro radiosensitivity in breast cancer cases but is not predictive of acute normal tissue reactions to radiotherapy.
Iwasaki T; Robertson N; Tsigani T; Finnon P; Scott D; Levine E; Badie C; Bouffler S
Int J Radiat Biol; 2008 Apr; 84(4):277-84. PubMed ID: 18386193
[TBL] [Abstract][Full Text] [Related]
4. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
5. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
[TBL] [Abstract][Full Text] [Related]
6. No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients.
El-Awady RA; Mahmoud M; Saleh EM; El-Baky HA; Lotayef M; Dahm-Daphi J; Dikomey E
Int J Radiat Biol; 2005 Jul; 81(7):501-8. PubMed ID: 16263653
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
De Ruyck K; Van Eijkeren M; Claes K; Morthier R; De Paepe A; Vral A; De Ridder L; Thierens H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1140-9. PubMed ID: 15990020
[TBL] [Abstract][Full Text] [Related]
8. Relationship between individual radiosensitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy.
Tang Y; Zhang Y; Guo L; Peng Y; Luo Q; Xing Y
Strahlenther Onkol; 2008 Oct; 184(10):510-4. PubMed ID: 19016039
[TBL] [Abstract][Full Text] [Related]
9. Normal tissue radiosensitivity in breast cancer patients.
Ramsay J; Birrell G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation.
Teh AY; Park EJ; Shen L; Chung HT
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1309-15. PubMed ID: 19427749
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
13. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
[TBL] [Abstract][Full Text] [Related]
14. In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients.
Oppitz U; Schulte S; Stopper H; Baier K; Müller M; Wulf J; Schakowski R; Flentje M
Int J Radiat Biol; 2002 Jul; 78(7):611-6. PubMed ID: 12079540
[TBL] [Abstract][Full Text] [Related]
15. Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes.
Borgmann K; Haeberle D; Doerk T; Busjahn A; Stephan G; Dikomey E
Radiother Oncol; 2007 May; 83(2):196-202. PubMed ID: 17499867
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
17. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer.
Hoeller U; Borgmann K; Bonacker M; Kuhlmey A; Bajrovic A; Jung H; Alberti W; Dikomey E
Radiother Oncol; 2003 Nov; 69(2):137-44. PubMed ID: 14643950
[TBL] [Abstract][Full Text] [Related]
18. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity.
Keller U; Kuechler A; Liehr T; Müller E; Grabenbauer G; Sauer R; Distel L
Strahlenther Onkol; 2004 May; 180(5):289-96. PubMed ID: 15127159
[TBL] [Abstract][Full Text] [Related]
19. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
[TBL] [Abstract][Full Text] [Related]
20. Potential for the G2/M arrest assay to predict patient susceptibility to severe reactions following radiotherapy.
Perez A; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
Strahlenther Onkol; 2007 Feb; 183(2):99-106. PubMed ID: 17294115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
